Episodes

  • How can we navigate COVID-19 in a new winter health landscape?

    How can we navigate COVID-19 in a new winter health landscape?
    Feb 2 2023
    Welcome to Health Conversation. Today we're asking Jo Atkinson, Anti-Infectives Product Lead at Pfizer, 'How can we navigate COVID-19 in a new winter health landscape?'. Listen to hear their discussion on the challenge and how we're preparing for the future.

    Hosted on Acast. See acast.com/privacy for more information.
    Show more Show less
    14 mins
  • What is the waiver impact on innovation and pandemic preparedness?

    What is the waiver impact on innovation and pandemic preparedness?
    Dec 12 2022
    Welcome to Health Conversation. Today we're asking Claire Skentelbery, Director General of EuropaBio, 'What is the waiver impact on innovation and pandemic preparedness?'. Listen to hear their discussion on the challenge and how we're preparing for the future.

    Hosted on Acast. See acast.com/privacy for more information.
    Show more Show less
    14 mins
  • Why is a therapeutics waiver extension different to the vaccine waiver?

    Why is a therapeutics waiver extension different to the vaccine waiver?
    Dec 5 2022
    Welcome to Health Conversation. Today we're asking Koen Berden, Executive Director for International Affairs at EFPIA, 'Why is a therapeutics waiver extension different to the vaccine waiver?'. Listen to hear their discussion on the challenge and how we're preparing for the future.

    Hosted on Acast. See acast.com/privacy for more information.
    Show more Show less
    17 mins
  • What would a TRIPS waiver extension mean for diagnostics?

    What would a TRIPS waiver extension mean for diagnostics?
    Nov 28 2022
    Welcome to Health Conversation. Today we're asking Jesús Rueda Rodríguez, Strategies, Special Projects & International Affairs Director General at MedTech Europe, 'What would a TRIPS waiver extension mean for diagnostics?'. Listen to hear their discussion on the challenge and how we're preparing for the future.

    Hosted on Acast. See acast.com/privacy for more information.
    Show more Show less
    15 mins
  • What would be the impact of a TRIPS waiver extension?

    What would be the impact of a TRIPS waiver extension?
    Nov 21 2022
    Welcome to Health Conversation. Today we're asking Peter Guenter, CEO of Healthcare at Merck, 'What would be the impact of a TRIPS waiver extension?'. Listen to hear their discussion on the challenge and how we're preparing for the future.

    Hosted on Acast. See acast.com/privacy for more information.
    Show more Show less
    17 mins
  • How can we support medical innovation in Europe?

    How can we support medical innovation in Europe?
    Apr 19 2022
    Welcome to Health Conversation. Today we're asking Nathalie Moll, Director General at EFPIA, 'How can we support medical innovation in Europe?'. Listen to hear their discussion on the challenge and how we're preparing for the future.

    Hosted on Acast. See acast.com/privacy for more information.
    Show more Show less
    22 mins
  • How can the EU be better prepared for cross-border health threats?

    How can the EU be better prepared for cross-border health threats?
    Dec 14 2021
    Welcome to 19 Conversations. Today we're asking Sara Cerdas, MEP and Mariano Votta, Director, Active Citizenship Network "How can the EU be better prepared for cross-border health threats?". Listen to hear their discussion on the challenge and how we're preparing for the future.

    Hosted on Acast. See acast.com/privacy for more information.
    Show more Show less
    34 mins
  • What is needed from the EMA to be better prepared for future health threats?

    What is needed from the EMA to be better prepared for future health threats?
    Dec 7 2021
    Welcome to 19 Conversations. Today we're asking Michel Stoffel, Senior Adviser Global Regulatory Affairs, GSK and Isabelle Bekeredjian-Ding, Head of Microbiology Division, Paul-Ehrlich-Institut "What is needed from the EMA to be better prepared for future health threats?". Listen to hear their discussion on the challenge and how we're preparing for the future.

    Hosted on Acast. See acast.com/privacy for more information.
    Show more Show less
    21 mins